Algal botanical extracts rich in eicosapentaenoic acid as tri/di-glyceride conjugate
AssigneeVaxa Technologies Ltd
InventorsOhad Bashan, Isaac Berzin
Life of this patent
Estimating the term…
Loading patent…
AssigneeVaxa Technologies Ltd
InventorsOhad Bashan, Isaac Berzin
Estimating the term…
Botanical extracts are provided, which comprise ethanol extracts of Nannochloropsis algae having between 1 wt % and 50 wt % polar lipids and between 45 wt % and 60 wt % fatty acids, wherein the fatty acids comprise more than 10 wt % of eicosapentaenoic acid (EPA) as triglyceride conjugates and/or diglyceride conjugates, and less than 15 wt % EPA as free fatty acids. EPA level may reach up to 90 wt %, and the botanical extract may be fluid at room temperature. Growth conditions are configured, adjusted and monitored to promote EPA formation in the cell vacuoles, resulting in a high proportion of EPA as tri/di-glyceride conjugates, as well as in a high concentration of Ω-3 fatty acids, which merely requires gentle extraction procedures to reach the final products, thereby maintaining the biochemical of the compounds without excessive modifications.
A food product or a nutritional supplement comprising an EPA (eicosapentaenoic acid) composition, the EPA composition comprising between 15 wt % and 90 wt % of EPA and between 10 wt % and 50 wt % of polar lipids, wherein:
A food product or a nutritional supplement comprising a botanical extract, the botanical extract comprising an ethanol extract of Nannochloropsis algae having between 10 wt % and 50 wt % polar lipids and between 45 wt % and 60 wt % fatty acids, wherein the fatty acids comprise:
A food product or a nutritional supplement comprising a botanical extract, the botanical extract comprising an ethanol extract of Nannochloropsis algae having between 10 wt % and 50 wt % polar lipids and between 45 wt % and 60 wt % fatty acids, wherein the fatty acids comprise:
Dependencies are inferred from the claim text.